WESTBOROUGH, Mass., Aug. 9, 2016 /PRNewswire-iReach/ -- Brie Stoianoff has joined The FDA Group in a newly created role as
Photo - http://photos.prnewswire.com/prnh/20160808/396420
For the past two years, she successfully led Vision 28 LLC as the President & CEO. Prior to Vision 28, she held Director of Quality and Regulatory roles at Acumed and CompView Medical. She also spent time at Welch Allyn, AstraZeneca, Shire, and DuPont Pharmaceutical Company (now Bristol-Myers Squibb.)
More about The FDA Group
The FDA Group is a global leader in GxP auditing & remediation and regulatory services. Their purpose is to empower our clients to bring their life-changing healthcare products to the market and keep them there.
The FDA Group is able to do this by providing a world-class service experience. The way in which The FDA Group ensures a world-class service experience is by its proprietary talent selection process coupled with its deep-rooted corporate culture that includes 31 Fundamentals. These Fundamentals are the heart-beat of the organization and are focused on four areas: Core Values, Focus on Service, The Collaborative Way, and Personal Effectiveness.
For more information, contact:
Andrea Houlne(508) [email protected]
Media Contact: Andrea Houlne, The FDA Group, 508-926-8330, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE The FDA Group
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All